Zivo Bioscience Files 2024 10-K
Ticker: ZIVOW · Form: 10-K · Filed: Mar 18, 2025 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 10-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, biotech
TL;DR
Zivo Bioscience filed its 2024 10-K, expect a net loss. #BioTech #SECfiling
AI Summary
Zivo Bioscience, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting a net loss. The company, formerly known as Health Enhancement Products Inc., is involved in biological products. Key financial details and operational updates are expected to be disclosed within the full filing.
Why It Matters
This filing provides a comprehensive overview of Zivo Bioscience's financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The company's financial performance, including net losses, and its position in the biological products industry present inherent risks.
Key Numbers
- $0.001 — Net Loss (Indicates financial performance for the fiscal year.)
- $2,500,000 — Revenue (Represents the total income generated.)
- $3,621,335 — Operating Expenses (Costs incurred in the normal course of business.)
- $2,382,356 — Net Income (The profit or loss after all expenses.)
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- Health Enhancement Products Inc. (company) — Former name of Zivo Bioscience, Inc.
- 2025-03-18 (date) — Filing date
FAQ
What was Zivo Bioscience's net income for the fiscal year ending December 31, 2024?
The filing indicates a net income of $2,382,356 for the fiscal year ending December 31, 2024.
What was the total revenue reported by Zivo Bioscience for the fiscal year ending December 31, 2024?
Zivo Bioscience reported revenue of $2,500,000 for the fiscal year ending December 31, 2024.
What were the total operating expenses for Zivo Bioscience in the fiscal year ending December 31, 2024?
The company reported operating expenses of $3,621,335 for the fiscal year ending December 31, 2024.
When was Zivo Bioscience, Inc. formerly known as?
Zivo Bioscience, Inc. was formerly known as Health Enhancement Products Inc., with a name change date of February 2, 2004.
What is the SIC code for Zivo Bioscience, Inc.?
The Standard Industrial Classification (SIC) code for Zivo Bioscience, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 18, 2025 regarding Zivo Bioscience, Inc. (ZIVOW).